Replies to post #4341 on Momenta Pharmaceuticals, Inc. (MNTA)

[go seek]

No one, I think...

but I for one am not complaining about the splendid return I have rec'd to date from MNTA... 'spect I speak for most here on that regard.

I expect we will be promoted to the 'majors' if/when mC is approved

Best,

[tekcor_atnm]

I didn't predict the market cap a year ago because I wasn't in the stock or a poster on iHub then, but I predicted back in March that MNTA would be as high as $19.50 (#msg-61282719 and #msg-65270490) on the 1-year anniversary of mEnoxaparin approval unless something major (positive or negative) happened. Pretty close with 3 days to go. MNTA being "gorilla glued" to $19.50 now. And as you can tell from what I stated in the prediction at the time, many people did not like it.

Using the channels on the chart as a guide all I can say is that I believe that MNTA will be between $13.50 and $19.50 on the 1 year anniversary of mEnoxaparin approval unless a major positive event occurs (mCopaxone approval, FOB partnership, TEVA throwing in the towel, the street recognizing significant earnings, etc.) -or- a negative event occurs (tEnoxaparin approval). Yes, $13.50 to $19.50 is below the $20+ MNTA hit upon approval and some people may not like that I say it, but hey I call it like I see it. In addition, I feel that there is a high liklihood of the positive events in the future, that's why I am looong Momenta Bank and Trust.